• By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
OK
Advertisement
In the last hour
In the last 2 hours
In the last 4 hours
In the last 6 hours
In the last 8 hours
Merck boosts viral vectors in California Chemical & Engineering News12:06
Earlier today
Yesterday
In the last 7 days
Merck’s COVID drug not as effective as first thought Proactive Investors (UK)10:46 26-Nov-21
UK to run study of Merck’s Covid pill The Irish Times07:25 26-Nov-21
FDA to Disclose Staff Review of Merck Covid-19 Pill The Wall Street Journal05:52 26-Nov-21
Gilead Trial Pause Adds To Merck & Co’s HIV Concerns Scrip Pharma Intelligence11:36 25-Nov-21
Merck and Dragonfly, Together Again BioSpace11:49 24-Nov-21
Gilead pause adds to Merck’s HIV doubts Evaluate Group10:50 24-Nov-21
view more headlines
29 Nov 18:39

Merck & Co News

NewsNow aims to be the world's most accurate and comprehensive aggregator of Merck & Co news, covering the latest MSD share price, Merck Sharp & Dohme company announcements, product trials, pharmaceutical news and more from the best online publications. Every story from every site is brought to you automatically and continuously 24/7, within around 10 minutes of publication. N.B. Relevance is automatically assessed so some headlines not qualifying as Merck & Co news might appear - please feel free to contact us regarding any persistent issues.
Read more

Publication filters

Headline Density

Sorry, no headlines or news topics were found. Please try different keywords.